Millions could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a report by KFF.

A new CMS pilot gives seniors $50 access to GLP-1 drugs like Wegovy, potentially reshaping food demand, nutrition strategies ...

The federal government is rolling out a new program that will enable some Medicare recipients to access GLP-1 weight loss ...

For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline ...

The Medicare GLP-1 Bridge Program has opened and will remain open through 2027, giving some Medicare beneficiaries greater ...

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock are in focus as Medicare offers coverage for GLP-1 weight-loss drugs for ...

A Medicare pilot program could expand access to GLP-1 weight-loss drugs for millions of seniors while lowering monthly costs to about $50.

The Centers for Medicare & Medicaid Services July 1 launched the Medicare GLP-1 Bridge, a short-term demonstration program designed to provide eligible Medicare Part D beneficiaries with access to ...

The Trump administration has officially launched its new "bridge" model that brings GLP-1 coverage for weight loss to Medicare beneficiaries. | The Trump administration has officially launched its new ...

The Centers for Medicare & Medicaid Services launched the Medicare GLP-1 Bridge program, an initiative designed to test the impact of increased access to GLP-1 drugs for weight management among ...